DGX logo

Quest Diagnostics Incorporated (DGX) EBITDA

Annual EBITDA:

$1.87B+$137.00M(+7.91%)
December 31, 2024

Summary

  • As of today, DGX annual EBITDA is $1.87 billion, with the most recent change of +$137.00 million (+7.91%) on December 31, 2024.
  • During the last 3 years, DGX annual EBITDA has fallen by -$1.29 billion (-40.84%).
  • DGX annual EBITDA is now -40.84% below its all-time high of $3.16 billion, reached on December 31, 2021.

Performance

DGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

Quarterly EBITDA:

$562.00M-$6.00M(-1.06%)
September 30, 2025

Summary

  • As of today, DGX quarterly EBITDA is $562.00 million, with the most recent change of -$6.00 million (-1.06%) on September 30, 2025.
  • Over the past year, DGX quarterly EBITDA has increased by +$87.00 million (+18.32%).
  • DGX quarterly EBITDA is now -39.57% below its all-time high of $930.00 million, reached on December 31, 2020.

Performance

DGX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

TTM EBITDA:

$2.15B+$87.00M(+4.23%)
September 30, 2025

Summary

  • As of today, DGX TTM EBITDA is $2.15 billion, with the most recent change of +$87.00 million (+4.23%) on September 30, 2025.
  • Over the past year, DGX TTM EBITDA has increased by +$329.00 million (+18.11%).
  • DGX TTM EBITDA is now -34.11% below its all-time high of $3.26 billion, reached on June 30, 2021.

Performance

DGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

DGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.9%+18.3%+18.1%
3Y3 Years-40.8%+11.3%-6.9%
5Y5 Years+17.9%-37.1%+11.9%

DGX EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-40.8%+7.9%-1.1%+38.1%-6.9%+19.8%
5Y5-Year-40.8%+17.9%-39.6%+38.1%-34.1%+19.8%
All-TimeAll-Time-40.8%+472.2%-39.6%+1928.9%-34.1%+5488.5%

DGX EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$562.00M(-1.1%)
$2.15B(+4.2%)
Jun 2025
-
$568.00M(+12.0%)
$2.06B(+4.1%)
Mar 2025
-
$507.00M(-0.4%)
$1.98B(+3.8%)
Dec 2024
$1.87B(+7.9%)
$509.00M(+7.2%)
$1.91B(+4.9%)
Sep 2024
-
$475.00M(-2.5%)
$1.82B(+0.6%)
Jun 2024
-
$487.00M(+12.0%)
$1.81B(+0.8%)
Mar 2024
-
$435.00M(+3.6%)
$1.79B(-0.7%)
Dec 2023
$1.73B(-4.8%)
$420.00M(-9.7%)
$1.80B(+0.7%)
Sep 2023
-
$465.00M(-1.7%)
$1.79B(-2.2%)
Jun 2023
-
$473.00M(+5.8%)
$1.83B(-2.2%)
Mar 2023
-
$447.00M(+9.8%)
$1.87B(-9.0%)
Dec 2022
$1.82B(-42.4%)
$407.00M(-19.4%)
$2.06B(-10.6%)
Sep 2022
-
$505.00M(-1.8%)
$2.30B(-10.3%)
Jun 2022
-
$514.00M(-18.8%)
$2.57B(-5.1%)
Mar 2022
-
$633.00M(-2.9%)
$2.71B(-5.2%)
Dec 2021
$3.16B(+31.0%)
$652.00M(-15.3%)
$2.86B(-8.9%)
Sep 2021
-
$770.00M(+18.1%)
$3.13B(-3.8%)
Jun 2021
-
$652.00M(-16.6%)
$3.26B(+9.9%)
Mar 2021
-
$782.00M(-15.9%)
$2.96B(+20.3%)
Dec 2020
$2.41B(+52.1%)
$930.00M(+4.1%)
$2.46B(+28.4%)
Sep 2020
-
$893.00M(+149.4%)
$1.92B(+33.8%)
Jun 2020
-
$358.00M(+27.4%)
$1.43B(-3.4%)
Mar 2020
-
$281.00M(-27.2%)
$1.48B(-4.2%)
Dec 2019
$1.58B(+12.9%)
$386.00M(-5.6%)
$1.55B(+2.2%)
Sep 2019
-
$409.00M(+0.2%)
$1.51B(+1.4%)
Jun 2019
-
$408.00M(+17.9%)
$1.49B(-0.5%)
Mar 2019
-
$346.00M(-1.7%)
$1.50B(-2.0%)
Dec 2018
$1.40B(-3.4%)
$352.00M(-9.3%)
$1.53B(-1.7%)
Sep 2018
-
$388.00M(-6.7%)
$1.56B(-0.8%)
Jun 2018
-
$416.00M(+10.3%)
$1.57B(+0.4%)
Mar 2018
-
$377.00M(-0.5%)
$1.56B(+0.9%)
Dec 2017
$1.45B(-1.8%)
$379.00M(-5.3%)
$1.55B(+1.3%)
Sep 2017
-
$400.00M(-2.2%)
$1.53B(+1.0%)
Jun 2017
-
$409.00M(+12.7%)
$1.52B(+1.3%)
Mar 2017
-
$363.00M(+1.1%)
$1.50B(+1.2%)
Dec 2016
$1.48B(-5.3%)
$359.00M(-6.8%)
$1.48B(+0.9%)
Sep 2016
-
$385.00M(-1.0%)
$1.47B(-1.1%)
Jun 2016
-
$389.00M(+12.8%)
$1.48B(-0.2%)
Mar 2016
-
$345.00M(-0.3%)
$1.49B(0.0%)
Dec 2015
$1.56B(+19.7%)
$346.00M(-13.9%)
$1.49B(-1.1%)
Sep 2015
-
$402.00M(+2.6%)
$1.50B(+1.4%)
Jun 2015
-
$392.00M(+13.6%)
$1.48B(+1.0%)
Mar 2015
-
$345.00M(-4.7%)
$1.47B(+2.4%)
Dec 2014
$1.30B(-26.3%)
$362.00M(-5.2%)
$1.43B(+0.5%)
Sep 2014
-
$382.00M(+1.1%)
$1.43B(+1.3%)
Jun 2014
-
$378.00M(+21.5%)
$1.41B(+0.3%)
Mar 2014
-
$311.00M(-12.3%)
$1.40B(-2.2%)
Dec 2013
$1.77B(+16.2%)
$354.47M(-2.6%)
$1.44B(-0.5%)
Sep 2013
-
$363.79M(-2.8%)
$1.44B(-4.1%)
Jun 2013
-
$374.37M(+9.3%)
$1.50B(-3.1%)
Mar 2013
-
$342.38M(-5.3%)
$1.55B(-3.1%)
Dec 2012
$1.52B(+17.0%)
$361.49M(-14.9%)
$1.60B(-2.4%)
Sep 2012
-
$425.00M(+0.5%)
$1.64B(+0.0%)
Jun 2012
-
$422.79M(+8.0%)
$1.64B(+0.2%)
Mar 2012
-
$391.42M(-2.2%)
$1.63B(+2.9%)
Dec 2011
$1.30B
$400.15M(-5.8%)
$1.59B(+1.6%)
Sep 2011
-
$424.68M(+1.4%)
$1.56B(+1.5%)
Jun 2011
-
$418.75M(+21.1%)
$1.54B(-0.7%)
DateAnnualQuarterlyTTM
Mar 2011
-
$345.84M(-7.8%)
$1.55B(-2.1%)
Dec 2010
$1.57B(-3.5%)
$375.18M(-6.4%)
$1.59B(-1.5%)
Sep 2010
-
$400.85M(-6.8%)
$1.61B(-0.7%)
Jun 2010
-
$430.05M(+13.3%)
$1.62B(+1.3%)
Mar 2010
-
$379.67M(-4.7%)
$1.60B(-0.4%)
Dec 2009
$1.63B(+11.0%)
$398.54M(-3.4%)
$1.61B(+0.1%)
Sep 2009
-
$412.50M(+0.9%)
$1.60B(+1.9%)
Jun 2009
-
$408.66M(+5.9%)
$1.57B(+2.3%)
Mar 2009
-
$386.07M(-2.6%)
$1.54B(+2.6%)
Dec 2008
$1.47B(+10.5%)
$396.38M(+3.6%)
$1.50B(+1.6%)
Sep 2008
-
$382.66M(+2.3%)
$1.48B(+0.6%)
Jun 2008
-
$373.89M(+7.8%)
$1.47B(+3.1%)
Mar 2008
-
$346.93M(-6.9%)
$1.42B(+6.0%)
Dec 2007
$1.33B(+0.3%)
$372.48M(-0.4%)
$1.34B(+3.6%)
Sep 2007
-
$373.83M(+13.2%)
$1.30B(+2.6%)
Jun 2007
-
$330.36M(+24.1%)
$1.26B(-0.1%)
Mar 2007
-
$266.20M(-18.4%)
$1.27B(-4.1%)
Dec 2006
$1.33B(+12.0%)
$326.33M(-4.3%)
$1.32B(+1.7%)
Sep 2006
-
$340.99M(+2.7%)
$1.30B(+3.8%)
Jun 2006
-
$331.87M(+3.4%)
$1.25B(+2.2%)
Mar 2006
-
$320.96M(+5.6%)
$1.22B(+4.1%)
Dec 2005
$1.18B(+12.8%)
$303.99M(+3.4%)
$1.18B(+3.6%)
Sep 2005
-
$293.92M(-3.7%)
$1.13B(+1.8%)
Jun 2005
-
$305.25M(+12.0%)
$1.12B(+2.0%)
Mar 2005
-
$272.65M(+3.7%)
$1.09B(+2.1%)
Dec 2004
$1.05B(+10.4%)
$262.87M(-4.1%)
$1.07B(+1.7%)
Sep 2004
-
$274.24M(-3.2%)
$1.05B(+2.0%)
Jun 2004
-
$283.17M(+13.3%)
$1.03B(+2.8%)
Mar 2004
-
$249.92M(+1.9%)
$1.00B(+5.2%)
Dec 2003
$950.36M(+31.3%)
$245.31M(-3.4%)
$954.28M(+7.3%)
Sep 2003
-
$253.85M(-0.4%)
$888.96M(+7.5%)
Jun 2003
-
$254.95M(+27.4%)
$827.02M(+8.1%)
Mar 2003
-
$200.18M(+11.2%)
$765.24M(+5.7%)
Dec 2002
$723.84M(+29.5%)
$179.98M(-6.2%)
$723.84M(+5.4%)
Sep 2002
-
$191.91M(-0.7%)
$686.67M(+7.8%)
Jun 2002
-
$193.17M(+21.7%)
$636.99M(+7.2%)
Mar 2002
-
$158.78M(+11.2%)
$594.04M(+6.2%)
Dec 2001
$559.12M(+23.7%)
$142.81M(+0.4%)
$559.12M(+7.3%)
Sep 2001
-
$142.23M(-5.3%)
$521.18M(+4.7%)
Jun 2001
-
$150.22M(+21.3%)
$497.97M(+5.1%)
Mar 2001
-
$123.85M(+18.1%)
$473.80M(+5.3%)
Dec 2000
$452.11M(+86.2%)
$104.88M(-11.9%)
$449.80M(+3.2%)
Sep 2000
-
$119.02M(-5.6%)
$435.85M(+13.3%)
Jun 2000
-
$126.06M(+26.2%)
$384.67M(+25.4%)
Mar 2000
-
$99.85M(+9.8%)
$306.80M(+24.6%)
Dec 1999
$242.80M(+48.9%)
$90.92M(+34.0%)
$246.17M(+27.1%)
Sep 1999
-
$67.85M(+40.8%)
$193.64M(+17.7%)
Jun 1999
-
$48.18M(+22.8%)
$164.54M(+2.2%)
Mar 1999
-
$39.22M(+2.1%)
$160.97M(-2.8%)
Dec 1998
$163.10M(+7.9%)
$38.40M(-0.9%)
$165.58M(+6.9%)
Sep 1998
-
$38.74M(-13.2%)
$154.88M(+0.7%)
Jun 1998
-
$44.61M(+1.8%)
$153.74M(-1.7%)
Mar 1998
-
$43.83M(+58.2%)
$156.33M(+3.6%)
Dec 1997
$151.10M(+130.1%)
$27.70M(-26.3%)
$150.90M(+22.5%)
Sep 1997
-
$37.60M(-20.3%)
$123.20M(+43.9%)
Jun 1997
-
$47.20M(+22.9%)
$85.60M(+122.9%)
Mar 1997
-
$38.40M
$38.40M
Dec 1996
-$502.19M
-
-

FAQ

  • What is Quest Diagnostics Incorporated annual EBITDA?
  • What is the all-time high annual EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual EBITDA year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?
  • What is Quest Diagnostics Incorporated TTM EBITDA?
  • What is the all-time high TTM EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?

What is Quest Diagnostics Incorporated annual EBITDA?

The current annual EBITDA of DGX is $1.87B

What is the all-time high annual EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual EBITDA is $3.16B

What is Quest Diagnostics Incorporated annual EBITDA year-on-year change?

Over the past year, DGX annual EBITDA has changed by +$137.00M (+7.91%)

What is Quest Diagnostics Incorporated quarterly EBITDA?

The current quarterly EBITDA of DGX is $562.00M

What is the all-time high quarterly EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly EBITDA is $930.00M

What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?

Over the past year, DGX quarterly EBITDA has changed by +$87.00M (+18.32%)

What is Quest Diagnostics Incorporated TTM EBITDA?

The current TTM EBITDA of DGX is $2.15B

What is the all-time high TTM EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high TTM EBITDA is $3.26B

What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?

Over the past year, DGX TTM EBITDA has changed by +$329.00M (+18.11%)
On this page